Deepcell Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif.--(BUSINESS WIRE)-- Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced that Maddison Masaeli, Ph.D., Co-Founder and Chief Executive Officer at Deepcell, will be presenting Wednesday, January 10, 2024 at the 42nd annual J.P. Morgan Healthcare Conference in San Francisco, Calif.

Event: J.P. Morgan 42nd Annual Healthcare Conference
Date: Wednesday, January 10th, 2024
Time: 3:00-3:25 p.m. PT

About Deepcell

Deepcell is a life science company which brings artificial intelligence to cell biology, unlocking a new field of high-dimensional biological discovery known as morpholomics. Through Deepcell’s AI-powered imaging and microfluidics solution, the REM-I Platform, the company is enabling a new scale of cell biology research and single cell analysis leveraging cellular morphology for unbounded discovery. Deepcell’s platform leverages its artificial intelligence model, the Human Foundation Model, to identify and sort cells based on morphological distinctions helping power basic and translational research and offering future applications in diagnostic testing and therapeutics targeting. The company was spun out of Stanford University in 2017 and has raised nearly $100 million in venture capital. It is based in Menlo Park, California. Learn more at www.deepcell.com or follow us on LinkedIn, Twitter, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240103471067/en/

Gwen Gordon
[email protected]

Source: Deepcell

You May Also Be Interested In

• Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
• HydraOS Adds Slack-Based Agent Layer With 4 Specialized Agents
• Baker Hughes and Venture Global Advance Next Phase of U.S. Gas Infrastructure Growth